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Invivo and Invitro Comparative Results  








The present paper reports on the derivatization of a polysaccharide (dextran), along 
with the bile acid binding capacities (invitro) and plasma lipid level lowering capacities 





Physico-chemical characteristics of the compounds tested as hypolipemic agents 
Aminic Groups Content, 
moli % 
Swoling in water at  equilibrium 
 (optimum domain) 
Gel 
Type A:  
m = 25 %, p = 0 
Type AB : 
 m+p = 55 mol % 
R1 R2 g H2O/g dry weight 
AB0 (A polymer ) Etil     55 Dodecil    0 3.967 
AB25 (Bpolymer) Etil    35 Dodecil  25 3.087 
 
The A and B compounds were compared to a commercially hypolipidemic drug, 
Cholestyramin, with the following results: 
• in vitro study of the values of the binding constants   determined for  sodium cholate 
(NaCA) showes that physico-chemical properties of these   polymers   can   influence   their   
binding   capacity   in the following manner:  B > A >Cholestyramin.  
• in  vivo results  differ   from  the  in vitro   data,   which   demonstrate   the   following order  
of  binding efficiencies:   Cholestyramin >B>A. The differences in the efficiency order for 
the binding of bile acids and the lowering of plasma lipid levels may be due to 
environmental variations in the digestive tract (pH, electrolytes, fatty acids).  Aminated 
polysaccharides administered in rats did not affect the digestive system, liver or pancreas 
functions. 
 
